- Home
- XCUR vs MF Comparison
XCUR vs MF Comparison
Compare XCUR & MF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
SELL
Current Price
$1.12
N/A
Current Price
$10.88
Company Overview
Basic Information| Metric | XCUR | MF |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 9.5M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XCUR | MF |
|---|---|---|
| Price | $1.12 | $10.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.4K | ★ 63.2K |
| Earning Date | 11-06-2026 | 12-29-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 83.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $44.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $5.07 |
| 52 Week High | $9.48 | $22.56 |
Technical Indicators
Market Signals| Indicator | XCUR | MF |
|---|---|---|
| Relative Strength Index (RSI) | 42.94 | 45.01 |
| Support Level | $1.05 | N/A |
| Resistance Level | $1.48 | $11.05 |
| Average True Range (ATR) | 0.09 | 2.18 |
| MACD | 0.01 | -0.52 |
| Stochastic Oscillator | 47.79 | 27.24 |
Price Performance
Historical Comparison XCUR
MF
About XCUR Exicure Inc.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.